Technical Analysis for BCT - Briacell Therapeutics Corp.

Grade Last Price % Change Price Change
F 3.010 0.33% 0.010
BCT closed up 0.33 percent on Thursday, April 25, 2024, on 21 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 0.33%
Oversold Stochastic Weakness 0.33%
Slingshot Bearish Bearish Swing Setup -4.44%
Spinning Top Other -4.44%
Narrow Range Bar Range Contraction -4.44%
Wide Bands Range Expansion -4.44%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Briacell Therapeutics Corp. Description

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

Is BCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.29
52 Week Low 2.8
Average Volume 10,144
200-Day Moving Average 6.393
50-Day Moving Average 3.870
20-Day Moving Average 3.439
10-Day Moving Average 3.065
Average True Range 0.225
RSI (14) 37.50
ADX 27.27
+DI 19.536
-DI 37.904
Chandelier Exit (Long, 3 ATRs) 3.405
Chandelier Exit (Short, 3 ATRs) 3.475
Upper Bollinger Bands 4.227
Lower Bollinger Band 2.650
Percent B (%b) 0.23
BandWidth 45.886
MACD Line -0.279
MACD Signal Line -0.265
MACD Histogram -0.0141
Fundamentals Value
Market Cap 2.32 Million
Num Shares 772 Thousand
EPS -0.04
Price-to-Earnings (P/E) Ratio -79.21
Price-to-Sales 0.00
Price-to-Book 10.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.145
Resistance 3 (R3) 3.137 3.083 3.123
Resistance 2 (R2) 3.083 3.049 3.088 3.115
Resistance 1 (R1) 3.047 3.028 3.065 3.055 3.107
Pivot Point 2.993 2.993 3.003 2.998 2.993
Support 1 (S1) 2.957 2.959 2.975 2.965 2.913
Support 2 (S2) 2.903 2.938 2.908 2.905
Support 3 (S3) 2.867 2.903 2.898
Support 4 (S4) 2.875